-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate total amount of expenses directly related to the marketing or selling of products or services.
-
Summary
-
GoodRx Holdings, Inc. quarterly/annual Selling and Marketing Expense history and growth rate from 2019 to 2024.
- GoodRx Holdings, Inc. Selling and Marketing Expense for the quarter ending March 31, 2024 was $90 M, a 14.6% increase year-over-year.
- GoodRx Holdings, Inc. Selling and Marketing Expense for the twelve months ending March 31, 2024 was $353 M, a 2.79% increase year-over-year.
- GoodRx Holdings, Inc. annual Selling and Marketing Expense for 2023 was $341 M, a 4.56% decline from 2022.
- GoodRx Holdings, Inc. annual Selling and Marketing Expense for 2022 was $358 M, a 3.4% decline from 2021.
- GoodRx Holdings, Inc. annual Selling and Marketing Expense for 2021 was $370 M, a 45.1% increase from 2020.
Selling and Marketing Expense, Trailing 12 Months (USD)
Selling and Marketing Expense, Quarterly (USD)
Selling and Marketing Expense, YoY Quarterly Growth (%)